Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Mulder

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Gut|February 21, 2013
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseBindia Jharap, Nanne K H de Boer, Pieter Stokkers, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 22, 2022
Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case SeriesAhmed B Bayoumy, Jasmijn Z Jagt, Herbert M van Wering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomasBegoña Diosdado, Tineke E Buffart, Russell Watkins, et al.
BMC Cancer|June 30, 2010
Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational studyJochim S Terhaar sive Droste, Frank A Oort, René W M van der Hulst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2015
Determinants of gliadin-specific T cell selection in celiac diseaseJan Petersen, Jeroen van Bergen, Khai Lee Loh, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the NetherlandsNicole M F van Gerven, Annemiek A van der Eijk, Suzan D Pas, et al.
Molecular Immunology|February 28, 2012
Origin and immunophenotype of aberrant IEL in RCDII patientsGreetje J Tack, Roy L J van Wanrooij, Anton W Langerak, et al.
Inflammatory Bowel Diseases|September 2, 2023
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease PatientsFemke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, et al.
Digestion|February 24, 2006
6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working partyN K H de Boer, W Reinisch, A Teml, et al.
BMC Cancer|December 20, 2013
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomasQuirinus J M Voorham, Jerry Janssen, Marianne Tijssen, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Gut|February 21, 2013
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseBindia Jharap, Nanne K H de Boer, Pieter Stokkers, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 22, 2022
Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case SeriesAhmed B Bayoumy, Jasmijn Z Jagt, Herbert M van Wering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomasBegoña Diosdado, Tineke E Buffart, Russell Watkins, et al.
BMC Cancer|June 30, 2010
Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational studyJochim S Terhaar sive Droste, Frank A Oort, René W M van der Hulst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2015
Determinants of gliadin-specific T cell selection in celiac diseaseJan Petersen, Jeroen van Bergen, Khai Lee Loh, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the NetherlandsNicole M F van Gerven, Annemiek A van der Eijk, Suzan D Pas, et al.
Molecular Immunology|February 28, 2012
Origin and immunophenotype of aberrant IEL in RCDII patientsGreetje J Tack, Roy L J van Wanrooij, Anton W Langerak, et al.
Inflammatory Bowel Diseases|September 2, 2023
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease PatientsFemke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, et al.
Digestion|February 24, 2006
6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working partyN K H de Boer, W Reinisch, A Teml, et al.
BMC Cancer|December 20, 2013
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomasQuirinus J M Voorham, Jerry Janssen, Marianne Tijssen, et al.
Pageof 29